The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.25BCNY
482.33M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
290.53MCNY
43.15M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-115.33%
Updated Aug 19, 2026
Beta
0.1520x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-70.41%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
3.25BCNY
482.33M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
3.60BCNY
534.45M · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
18.92x
Updated Aug 19, 2026
Price to Sales (TTM)
12.28x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 11.18×.Updated Aug 19, 2026
Price to Book (MRQ)
3.53x
Updated Aug 19, 2026
Enterprise to Revenue
12.39x
Updated Aug 19, 2026
Enterprise to EBITDA
-11.40x
Updated Aug 19, 2026
Gross Margin
69.01%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 62.33%.Updated Aug 19, 2026
Profit Margin
-115.33%
Updated Aug 19, 2026
Operating Margin
-103.35%
Updated Aug 19, 2026
Return on Assets (TTM)
-11.04%
Updated Aug 19, 2026
Return on Equity (TTM)
-28.98%
Updated Aug 19, 2026
Revenue (TTM)
290.53MCNY
43.15M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
0.2000CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-24.90%
Updated Aug 19, 2026
Gross Profit (TTM)
181.08MCNY
26.89M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
-315.61MCNY
-46.87M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-335.05MCNY
-49.76M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-66.66%
Updated Aug 19, 2026
Operating Cash Flow (TTM)
66.55MCNY
9.88M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
263.22MCNY
39.09M · vs all stocks (USD)
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.26%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
0.00%
Updated Aug 19, 2026
Minority Interest (Equity)
-11.56MCNYFY2025 · Dec 31, 2025
Revenue
305.86MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
123.38MCNYFY2025 · Dec 31, 2025
Gross Profit
182.48MCNYFY2025 · Dec 31, 2025
Operating Income
-199.63MCNY
-29.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-363.55MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-22.10MCNYFY2025 · Dec 31, 2025
Net Income
-341.45MCNYFY2025 · Dec 31, 2025
EBIT
-357.08MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-125.45MCNYFY2025 · Dec 31, 2025
Research & Development
136.92MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
100.60MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.40MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
306.56KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.47MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2331CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2331CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.45BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.45BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-341.45MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.44MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-301.78MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-310.98MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
38.90MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-341.45MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
9.11MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
21.16MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
9.40MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-9.20MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-74.56MCNYFY2025 · Dec 31, 2025
Sale of Investments
91.67MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
7.91MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
179.37MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-242.10MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-5.29MCNYFY2025 · Dec 31, 2025
Other Financing Charges
847.36KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-67.18MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.45BSharesUpdated Aug 19, 2026
Float Shares
1.14BSharesUpdated Aug 19, 2026
% Held by Insiders
21.79%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
0.91%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
56.15MCNY
8.34M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
0.0390CNYUpdated Aug 19, 2026
Total Debt (MRQ)
100.12MCNY
14.87M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.1003x
Updated Aug 19, 2026
Current Ratio (MRQ)
0.9080x
Updated Aug 19, 2026
Book Value per Share (MRQ)
0.6970CNYUpdated Aug 19, 2026
Total Assets
1.80BCNY
267.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
715.08MCNYFY2025 · Dec 31, 2025
Total Liabilities
754.41MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.09BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
8.67MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
745.74MCNYFY2025 · Dec 31, 2025
Cash
40.36MCNYFY2025 · Dec 31, 2025
Cash Equivalents
6.60MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
46.96MCNYFY2025 · Dec 31, 2025
Accounts Receivable
310.43MCNYFY2025 · Dec 31, 2025
Inventory
277.23MCNYFY2025 · Dec 31, 2025
Accounts Payable
139.14MCNYFY2025 · Dec 31, 2025
Short-term Debt
155.62MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
103.97MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.72MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.45BCNYFY2025 · Dec 31, 2025
Retained Earnings
-745.33MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.05BCNY
155.76M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.03CNYUpdated Aug 19, 2026
52-Week High
8.28CNYUpdated Aug 19, 2026
52-Week Change
-70.41%
vs all stocks
Updated Aug 19, 2026
Beta
0.1520x
vs all stocks
Updated Aug 19, 2026
50-Day MA
2.58CNYUpdated Aug 19, 2026
200-Day MA
5.25CNYUpdated Aug 19, 2026
Avg 10-Day Volume
21.61MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
24.75MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-0.2300CNYUpdated Aug 19, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.69Profit Margin: -1.15
Financial Health
Altman Z-Score 1.5: grey zoneSignificant
Altman Z-Score: 1.50
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Levered free cash flow is $39.09M, above the global median of $16.24MNotable
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedPartial Recovery After Sharp Decline
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedPartial Recovery After Sharp Decline
Decline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedPartial Recovery After Sharp Decline